LONDON (AP) — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator.
In an update on the European Medicines Agency’s website Wednesday, the regulator said that the approval for AstraZeneca’s Vaxzevria had been withdrawn “at the request of the marketing authorization holder.”
AstraZeneca’s COVID-19 vaccine was first given the nod by the EMA in January 2021. Within weeks, however, concerns grew about the vaccine’s safety, when dozens of countries suspended the vaccine’s use after unusual but rare blood clots were detected in a small number of immunized people. The EU regulator concluded AstraZeneca’s shot didn’t raise the overall risk of clots, but doubts remained.
Partial results from its first major trial — which Britain used to authorize the vaccine — were clouded by a manufacturing mistake that researchers didn’t immediately acknowledge. Insufficient data about how well the vaccine protected older people led some countries to initially restrict its use to younger populations before reversing course.
Related articles:
Related suggestion:
In Argentina, the government's austerity plan hits universities and provokes student protestsGoFundMe expands into Mexico as part of forUnitedHealth says wide swath of patient files may have been taken in Change cyberattackLana Del Rey Coachella performance lands organizers $28K FINERebel Wilson's explosive memoir is set to be published in the UKAaron TaylorGoogle fires more workers who protested its deal with IsraelArmenia and Azerbaijan move closer to normalizing ties as the first border marker goes upAnalysis: The IndyCar season has just started but free agency is in full swing after only 2 racesQB Bryce Young excited about 'new faces' in Carolina after team's 2
3.5105s , 6500.078125 kb
Copyright © 2024 Powered by AstraZeneca pulls COVID vaccine from European market ,Global Genesis news portal